Fasting glucose improved within weeks and my HbA1c barely moved for three months, which I now understand and did not at the time.
The bit I cannot resolve on my own is why A1C lags the way it does, and what to look at in the meantime if you want to know sooner.
Happy to be told the question itself is wrong.
JessicaH_TX said:Fasting glucose improved within weeks and my HbA1c barely moved for three months, which I now understand and did not at the time.
Complete metabolic panel trending on glycaemic control — sharing because comprehensive data helps everyone:
| Test | Baseline | Month 3 | Month 6 | Month 12 |
|---|---|---|---|---|
| Glucose (fasting) | 124 | 106 | 92 | 84 |
| Insulin (fasting) | 20 | 14 | 8 | 7 |
| HOMA-IR | 4.5 | 3.0 | 2.0 | 1.3 |
| Uric Acid | 7.7 | 6.4 | 5.9 | 5.0 |
The insulin resistance improvement (HOMA-IR) is what my endo focuses on most. Going from 4.5 to near 1.0 is a metabolic transformation.
mike.trainer_LA said:Complete metabolic panel trending on glycaemic control — sharing because comprehensive data helps everyone: Test Baseline Month 3 Month 6 Month 12…
Glycemic variability as the key metric for glycaemic control success: my coefficient of variation (CV) on CGM dropped from 37% to 18%. Target is <36%, with <30% being ideal.
Why this matters more than average glucose: large glucose swings cause oxidative stress, endothelial damage, and promote advanced glycation end-products (AGEs). A flat glucose line at 95 mg/dL is metabolically healthier than oscillating between 60 and 160, even if the average is the same.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsJessicaH_TX said:Fasting glucose improved within weeks and my HbA1c barely moved for three months, which I now understand and did not at the time.
This is my experience too, for whatever a second data point is worth.
From the other side of the consultation, briefly.
PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.
After 10 months: periods became regular for the first time in years, testosterone levels normalized, acne cleared significantly, and — unexpectedly — I got pregnant naturally after 4 years of trying.
GLP-1 agonists address the insulin resistance at the root of PCOS. For PCOS patients, this isn't "just" a weight loss drug — it's treating our underlying metabolic dysfunction.